Part the Cloud
Funded by Alzheimer's Association
Alzheimer's Association research grants that move promising Alzheimer's and dementia treatments into early-stage human clinical trials.
Part the Cloud is the Alzheimer's Association's grant program for translational research on Alzheimer's disease and other dementias. It offers three kinds of funding: the Translational Research Grant Program, which backs science ready for early human trials; the Enable the Molecule for Therapeutics program, which supports drug development at the stage before an investigational new drug filing; and topic-specific Challenges. Funded research areas include metabolic function, cell signaling, cell senescence, immune response, amyloid and tau, vascular and oxidative stress, and genome sequencing.
The translational research program aims to increase early-stage human clinical trials, Phase 1 and Phase 2, of new or repurposed medications. It can fund first-in-human testing of lead candidates, small proof-of-mechanism pilots, small trials of repurposed drugs, and work validating biomarkers of disease progression in a trial setting. Universities, hospitals, medical centers, research laboratories and for-profit organizations can apply, and international applicants are encouraged. Applications go through ProposalCentral, starting with a letter of intent.
What it funds
- Early-stage (Phase 1 and small Phase 2a) human clinical trials of new or repurposed drugs for Alzheimer's and related dementias
- Small pilot proof-of-mechanism studies for therapies with established human safety data
- Proof-of-concept work to validate biomarkers of disease progression in a trial setting
- Therapeutic development at the IND-enabling stage, through the Enable the Molecule program
- Topic-specific Challenges announced by the Association
Who can apply
- Public and private universities, medical centers, hospitals and research laboratories
- For-profit organizations, including small for-profit groups
- Principal investigators holding a full-time position equivalent to Assistant Professor or above; postdocs may serve only as key personnel
- International applicants, including US organizations; US and foreign government-appropriated laboratories cannot be the applicant institution
- Proposals must focus clearly on Alzheimer's and related disorders and be translational
How to apply
- Check the current request for applications on the alz.org Part the Cloud and Types of Grants pages
- Submit a letter of intent through ProposalCentral
- If the letter of intent is accepted, submit a full application through ProposalCentral
- Each investigator may submit only one proposal across the current competition
Part the Cloud: common questions
Can a company apply?
Yes. The program page states that for-profit organizations are eligible, including small for-profit groups.
Can postdoctoral fellows apply?
No. Postdocs can be listed as key personnel, but the applicant must hold a position equivalent to Assistant Professor or above.
Are applicants outside the US eligible?
Yes. The program encourages international applicants; US-based institutions are also eligible.
Can I submit more than one proposal?
No. Only one proposal is allowed per investigator across the programs in a given competition.
Before you apply
Amounts, eligibility and deadlines change every cycle. Read the current solicitation on the official page before you start an application.
More for startups
- 01Breakthrough Energy Explorer GrantBreakthrough EnergyGrants for early-stage, high-risk climate technology research, typically led by scientists in a university lab or research organization.RollingStartups
- 02Parkinson's Disease Therapeutics Pipeline ProgramThe Michael J. Fox Foundation for Parkinson's ResearchThe Michael J. Fox Foundation's flagship program funding preclinical and clinical development of new Parkinson's disease therapies, mainly for companies.RollingStartups
- 03Small Business Innovation Research (SBIR)US federal agencies (coordinated by SBA)Federal R&D funding for US small businesses developing technology with commercial potential. Eleven agencies run their own SBIR solicitations.StartupsSmall businesses